ArticleAdvances in radiation oncology2025
Self-Reported Health Status Survey Creation and Distribution Outcomes in a Large Cohort of Pediatric Oncology Patients Treated with Proton Radiation Therapy.
Article in Advances in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Most pediatric patients receiving radiation therapy at Massachusetts General Hospital are referred from outside institutions and later return to their original care providers. As quaternary care centers, proton therapy centers face unique challenges in tracking patient follow-up, yet obtaining longitudinal data is crucial for assessing radiation therapy outcomes. We implemented an annual direct-to-patient survey to improve follow-up data collection. Methods and Materials: The survey was designed to be completed in <5 minutes and records contact information, health status (recent follow-up and with which specialists, imaging, the status of treated disease/secondary tumors, additional treatments, and symptoms), and social updates. Surveys were sent annually as mailed letters with a quick response code or by e-mail using research electronic data capture software. Data were collected between February 2019 and June 2022. Approval was obtained to send surveys to oncology patients prospectively enrolled in a clinical trial or the Pediatric Proton/Photon Consortium Registry at our single institution. Results: Of the 472 participants who were sent at least 1 survey, 236 (50%) responded. Patients who received surveys via e-mail were 1.6 times as likely to respond than those who received surveys via mail ( Conclusions: Survey implementation improved follow-up data collection, with e-mail being more effective than mail as a distribution method. Adaptation and utilization of our survey in other tertiary and quaternary centers may improve the collection of patient outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.